# Patriot National Bancorp Inc: overview PNBK · Nasdaq · CIK 1098146 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/pnbk.md) · [Financials](/companies/pnbk/financials.md) · [Filings](/companies/pnbk/filings.md) · [Insiders](/companies/pnbk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(6.78)](/filings/0001628280-25-052358.md) | not reported | [(0.21)](/filings/0001628280-26-035706.md) | [(0.06)](/filings/0001628280-26-057183.md) | [(0.03)](/filings/0001628280-25-052358.md) | not reported | [(0.02)](/filings/0001628280-26-035706.md) | [0.00](/filings/0001628280-26-057183.md) | | Free cash flow | $k | [(2,652) d](/filings/0001628280-25-052358.md) | [(2,669) d](/filings/0001628280-26-022508.md) | [(5,881)](/filings/0001628280-26-035706.md) | [919 d](/filings/0001628280-26-057183.md) | [(5,258) d](/filings/0001628280-25-052358.md) | [(4,122) d](/filings/0001628280-26-022508.md) | [(3,457)](/filings/0001628280-26-035706.md) | [(5,666) d](/filings/0001628280-26-057183.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.29](/filings/0001628280-24-013983.md) | [1.55](/filings/0001628280-25-017837.md) | [(1.05)](/filings/0001628280-26-022508.md) | [(10.03)](/filings/0001628280-26-022508.md) | [(0.17)](/filings/0001628280-26-022508.md) | | Free cash flow | $m | [7.2](/filings/0001628280-24-013983.md) | [6.6](/filings/0001628280-25-017837.md) | [(11.1)](/filings/0001628280-26-022508.md) | [2.6](/filings/0001628280-26-022508.md) | [(14.3)](/filings/0001628280-26-022508.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pnbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.2m | 4,346,777 | | Reduced −54,755 | | [Angel Oak Capital Advisors, LLC](/funds/1613158.md) | 2026-06-30 | $2.5m | 2,662,136 | | Reduced −504,123 | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $1.8m | 1,919,309 | | Added +440 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $945.1k | 986,548 | | Reduced −870,559 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $720.7k | 752,658 | | New +752,658 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $610.3k | 637,425 | | Reduced −3,132,548 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $511.2k | 533,646 | | Reduced −97,971 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $471.9k | 491,531 | | New +491,531 | | [Composition Wealth, LLC](/funds/1585859.md) | 2026-06-30 | $416.3k | 434,748 | | Unchanged | | [Curated Wealth Partners LLC](/funds/1781284.md) | 2026-06-30 | $409.8k | 427,980 | | Reduced −399,360 | ## Recent filings [All 636 filings](/companies/pnbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-24 | 20:33 ET | [8-K](/filings/0001437749-26-031152.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-031152 | | 2026-09-23 | 13:15 ET | [8-K](/filings/0001437749-26-031012.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-031012 | | 2026-08-17 | 12:00 ET | [8-K](/filings/0001437749-26-028110.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-028110 | | 2026-08-14 | 21:29 ET | [10-Q](/filings/0001628280-26-057183.md) | Quarterly report, period 2026-06-30 | 0001628280-26-057183 | | 2026-07-31 | 12:12 ET | [8-K](/filings/0001437749-26-025169.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-025169 | | 2026-07-13 | 10:01 ET | [8-K](/filings/0001437749-26-023372.md) | 7.01 Regulation FD disclosure | 0001437749-26-023372 | | 2026-07-01 | 10:09 ET | [8-K](/filings/0001437749-26-022212.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-022212 | | 2026-05-26 | 20:06 ET | [8-K](/filings/0001437749-26-018374.md) | 5.07 Shareholder vote results | 0001437749-26-018374 | | 2026-05-15 | 21:06 ET | [10-Q](/filings/0001628280-26-035706.md) | Quarterly report, period 2026-03-31 | 0001628280-26-035706 | | 2026-05-06 | 01:08 ET | [8-K](/filings/0001437749-26-014990.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-014990 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-022508.md), filed Mar 31, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1098146 - Tickers: PNBK - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: CT - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.